Mayo Clinic Proceedings

Bax, Jeroen J.; Schuijf, Joanne D.
January 2008
Mayo Clinic Proceedings;Jan2008, Vol. 83 Issue 1, p10
Academic Journal
The article discusses the association of coronary calcification and myocardial perfusion scintigraphy (MPS). It has an essential role in diagnosis and management of patients presenting with known or suspected coronary artery disease. It is also the most commonly used and well-documented noninvasive method for risk stratification.


Related Articles

  • Coronary vasomotion in patients with syndrome X: evaluation with positron emission tomography and parametric myocardial perfusion imaging. Meeder, Joan G.; Blanksma, Paul K.; van der Wall, Ernst E.; Willemsen, Antoon T. M.; Pruim, Jan; Anthonio, Rutger L.; de Jong, Richard M.; Vaalburg, Willem; Lie, Kong I. // European Journal of Nuclear Medicine;1997, Vol. 24 Issue 5, p530 

    The aim of this study was to elucidate further the causative mechanism of abnormal coronary vasomotion in patients with syndrome X. In patients with syndrome X, defined as angina pectoris and documented myocardial ischaemia during stress testing with normal findings at coronary angiography,...

  • Identifikacija rezidualne ishemije u zoni irigacije okludirane koronarne arterije perfuzionom scintigrafijom miokarda. Baškot, Branislav; Obradović, Slobodan; Gligić, Branko; Rafajlovski, Sašo; Marković, Ljuba; Pavlović, Miodrag // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Nov2007, Vol. 64 Issue 11, p783 

    Background. Inspite the indisputable significance of coronarography, the implications of a revealed stenosis - and how close it is to occlusion could vary in regard to its physiological importance. Myocardial perfusion scintigraphy (MPS) possiblity to prove and objectivise the presence of...

  • Motion detection and correction for dynamic 15O-water myocardial perfusion PET studies. Naum, Alexandru; Laaksonen, Marko S.; Tuunanen, Helena; Oikonen, Vesa; Teräs, Mika; Kemppainen, Jukka; Järvisalo, Mikko J.; Nuutila, Pirjo; Knuuti, Juhani // European Journal of Nuclear Medicine & Molecular Imaging;Dec2005, Vol. 32 Issue 12, p1378 

    Purpose: Patient motion during dynamic PET studies is a well-documented source of errors. The purpose of this study was to investigate the incidence of frame-to-frame motion in dynamic 15O-water myocardial perfusion PET studies, to test the efficacy of motion correction methods and to study...

  • "No-Reflow" Phenomenon Following Percutaneous Coronary Intervention: An Uncommon Complication. Safi, Arshad M.; Kwan, Tak W. // Angiology;Mar2000, Vol. 51 Issue 3, p247 

    The no-reflow phenomenon has been recognized as an uncommon complication after reperfusion therapy (thrombolytic or mechanical) for acute myocardial infarction and after percutaneous coronary intervention. As management and outcomes differ, early diagnosis and angiographic exclusion of other...

  • Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: results from the AMI-QUEBEC Study. Thao Huynh; O'Loughlin, Jennifer; Joseph, Lawrence; Schampaert, Erick; Rinfret, Stéphane; Afilalo, Marc; Kouz, Simon; Cantin, Bernard; Nguyen, Michel; Eisenberg, Mark J. // CMAJ: Canadian Medical Association Journal;12/5/2006, Vol. 175 Issue 12, p1527 

    Background: Through the AMI-QUEBEC Study we sought to describe delays to reperfusion therapy for ST-segment elevation myocardial infarction (STEMI) and to identify factors associated with prolonged delays. Methods: We reviewed the charts of all consecutive patients with STEMI admitted to 17...

  • Systemic Inflammation and Reperfusion Injury in Patients With Acute Myocardial Infarction. Blancke, Fien; Claeys, Marc J.; Jorens, Philippe; Vermeiren, Guy; Bosmans, Johan; Wuyts, Floris L.; Vrints, Chris J. // Mediators of Inflammation;12/14/2005, Vol. 2005 Issue 6, p385 

    Despite early recanalization of an occluded infarct artery, tissue reperfusion remains impaired in more than one-third of the acute myocardial infarction (AMI) patients owing to a process of reperfusion injury. The role of systemic inflammation in triggering this phenomenon is unknown....

  • INDIGENOUS RECOMBINANT STREPTOKINASE VS NATURAL STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION PATIENTS: PHASE III MULTICENTRIC RANDOMIZED DOUBLE BLIND TRIAL. Diwedi, S. K.; Hiremath, J. S.; Kerkar, P. G.; Reddy, Krishna N.; Manjunath, C. N.; Ramesh, S. S.; Prabhavati, S.; Dhobe, M.; Singh, Kavita; Bhusari, P.; Rao, Raman // Indian Journal of Medical Sciences;May2005, Vol. 59 Issue 5, p200 

    BACKGROUND: Streptokinase is the most widely used thrombolytic agent and can now be made using recombinant DNA technology. The present trial was initiated to assess an indigenous recombinant streptokinase (Shankinase, r-SK). AIM: To compare the efficacy and safety of indigenous recombinant...

  • The Open Artery Hypothesis: Beneficial Effects and Long-term Prognostic Importance of Patency of the Infarct-Related Coronary Artery. Centurion, Osmar Antonio // Angiology;Feb/Mar2007, Vol. 58 Issue 1, p34 

    There seem to be additional mechanisms of benefit in patients receiving late reperfusion therapy in a time when the opportunity for myocardial salvage has been missed. Previous studies have demonstrated that the restoration of blood flow in the infarct-related coronary artery in patients with...

  • Myocardial Ischaemia-Reperfusion Syndrome. ALDANA BITAR, JAIRO ALEJANDRO; PACHECO, DAVID SANTACRUZ; URINA TRIANA, MANUEL ELISEO // Universitas Médica;abr-jun2014, Vol. 55 Issue 2, p166 

    Reperfusion is the definitive treatment to salvage ischemic myocardium from infarction. A primary determinant of infarct size is the duration of ischemia. Early reestablishment of blood flow to ischaemic myocardium limits infarct size and reduces mortality. In a paradoxical manner, the return of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics